MRC and DfID contribution to jointly funded rapid response strategic award.

战略奖的细节使阿德里安希尔教授牛津大学埃博拉1期试验加速单价载体埃博拉疫苗的临床评价西非埃博拉疫情已从几内亚蔓延到几个国家，并构成持续的威胁。世卫组织已宣布这是一个国际突发公共卫生事件。目前的提案旨在首次在英国和西非与美国国立卫生研究院的合作者一起在人类中测试最合适的埃博拉潜在候选疫苗，以确定其安全性和免疫原性。如果这些试验在2014年成功完成，世卫组织将有可能在2015年初部署这种疫苗。

Details of the Strategic Award made Professor Adrian Hill Oxford University Ebola Phase 1 trial Accelerated Clinical Evaluation of Monovalent vectored Ebola vaccineAn outbreak of Ebola in West Africa has spread from Guinea to several countries and presents a continuing threat. WHO have declared this an international public health emergency. The current proposal aims to test the most suitable potential vaccine candidate for Ebola in humans for the first time, in the UK and West Africa, in parallel with collaborators at NIH, to determine its safety and immunogenicity. Successful completion of these trials in 2014 would provide WHO with the option of deploying this vaccine early in 2015.